eLife Submission Process

Use this page when you want to understand:

• what happens after submission

• how the editorial screen works in the reviewed-preprint model

• when the public assessment appears

• what optional revision and Version of Record steps actually mean

If you still need help deciding whether the package and team are ready for the model, see the eLife submission guide.

The process goes better when the manuscript already behaves like an eLife submission before the portal opens:

• the team is comfortable with preprint-first publication

• the paper can tolerate public critique

• the open-science materials are already in good shape

That is why the workflow question starts before submission.

• eLife public-assessment mismatch: the title and abstract still sound exploratory even though the eLife Assessment will publicly grade significance and evidence.

• eLife evidence-readiness gap: the first figures contain unresolved controls, weak quantification, or limitation language that authors would normally repair before private review.

• eLife model-fit misunderstanding: the cover letter treats eLife like a traditional accept/reject journal rather than a reviewed-preprint system where public reviews and assessment language become part of the publication record.

Check whether your eLife public-assessment package is ready →

Check if your eLife evidence package can tolerate public review →

Check whether your eLife cover letter fits the reviewed-preprint model →

In a traditional journal, peer review is private and the outcome is a binary accept or reject. At eLife, peer review is public and the outcome is a Reviewed Preprint with transparent feedback.

This means:

• your paper does not get "rejected" in the traditional sense after peer review

• the reviewer feedback and eLife Assessment are published alongside your preprint

• you choose when (or whether) to submit a revised version

• you choose when to convert the Reviewed Preprint into a formal Version of Record

The model separates the peer review function (feedback and evaluation) from the publication decision (which stays with the author). This is a fundamental shift from how most journals operate.

The early stage is not just an editor opinion on scientific quality. Editors are effectively testing whether:

• the paper is significant enough to justify public review

• the evidence is strong enough that a public assessment is worth publishing

• the manuscript fits eLife's life-science scope

• the authors appear to understand the model they are entering

That is why a strong paper can still be a weak eLife submission if the model fit is poor.

eLife only reviews papers that are available as preprints. If you have not posted a preprint, you can do so during the submission process. eLife will ask about preprint status during submission and can facilitate posting to bioRxiv.

This is not negotiable. The entire model depends on the work being publicly available before review.

1. Post or confirm preprint

Before peer review starts, the manuscript must be publicly available as a preprint, and you include the preprint DOI in your submission if you have one. eLife reviews only papers that exist as preprints, so this step is mandatory rather than optional. You do not need to have posted a preprint for the initial evaluation: if you have not, eLife can facilitate posting to bioRxiv or medRxiv, and eLife says it can support any recognised preprint server that supports versioning.

2. Submit via eLife's system

Go to eLife's submission portal. Provide the preprint link, cover letter, author information, and declarations. Select the research area that best matches your work. Have your data availability, ethics, and conflict-of-interest statements ready, since they are part of the initial submission rather than later additions.

3. Editorial evaluation

A senior editor paired with a reviewing editor evaluates whether the paper should be sent for peer review. They assess:

• significance of the findings within the field

• whether the paper reports results of broad interest

• methodological soundness at a high level

• fit with eLife's editorial scope (biomedical and life sciences)

The editorial screen is the main filter and the most selective step in the process. If your paper passes editorial evaluation, it is very likely to receive a complete Reviewed Preprint with full reviewer feedback and a public eLife Assessment. The important distinction is that the real gating decision happens before review, not after it.

4. Peer review

Papers that pass editorial screening go to expert reviewers. Each reviewer writes a Public Review and recommendations for the authors, and the reviewers and editor then write the eLife Assessment together.

The eLife Assessment evaluates two dimensions:

• Significance of findings: landmark, fundamental, important, valuable, or useful

• Strength of evidence: exceptional, compelling, convincing, solid, incomplete, or inadequate

These terms have specific meanings in eLife's framework and appear publicly alongside the Reviewed Preprint.

5. Reviewed Preprint published

Within about 2 weeks of review completion, eLife publishes the Reviewed Preprint on its website. This includes the paper, the eLife Assessment, the Public Reviews, and the author response (if provided).

This is a citable publication with a DOI. It is not a draft or a provisional version. It is a peer-reviewed preprint with transparent evaluation.

6. Revision and Version of Record

After receiving the reviews, authors can:

• revise the manuscript and submit an updated version for possible re-review

• publish a Version of Record (formal journal article) at any point after review

• leave the Reviewed Preprint as the final publication

There is no fixed deadline for revision, but eLife asks authors to tell it if a revision will take longer than 12 months.

eLife charges $3,750 when the preprint is sent for peer review. This covers the editorial evaluation, peer review, Reviewed Preprint publication, any subsequent re-reviews, and the Version of Record. Fee waivers are available for authors who cannot pay.

The fee does not depend on the outcome of peer review. Even if the eLife Assessment is unfavorable, the Reviewed Preprint is published (eLife says it will refund any fees already paid if it ends the review because it cannot provide high-quality public reviews).

The useful question at eLife is not only how many weeks have passed. It is where the paper is inside a model that publishes review outputs publicly.

• early quiet usually means editorial suitability for reviewed-preprint publication is being judged

• active review time means the paper is already on track for public assessment if it stays in the process

• post-review waiting often reflects preparation of the Reviewed Preprint package and assessment materials, not a hidden accept or reject debate

That is why authors should read eLife timing differently from a conventional journal.

An Assessment rating of "incomplete" evidence or "useful" significance is less favorable, but the Reviewed Preprint is still a peer-reviewed publication. Authors can revise and request re-review to improve the Assessment.

Yes. A Reviewed Preprint is a peer-reviewed publication in eLife, and the Version of Record is a traditional journal article. Both carry a DOI and are citable. If your institution or funder expects a conventional accept decision, note that eLife produces a public assessment rather than a binary acceptance, so confirm how your reporting process treats a Reviewed Preprint before you rely on it.

The initial Assessment is published with the first Reviewed Preprint. If authors revise and the revision is re-reviewed, the Assessment can be updated. Both versions remain visible.

For manuscripts targeting eLife, three patterns generate the most consistent editorial screen failures among the papers we analyze.

The failure pattern is usually public-review mismatch: the manuscript might survive private peer review, but the preprint, figure package, and limitation language are not ready to carry a visible eLife Assessment.

Authors who don't understand the model before submitting

eLife's editors decide whether a submission is suitable for peer review by experts. We see authors submitting without recognizing that the peer review will be public and permanently attached to the preprint. Manuscripts where the authors have included speculative claims, preliminary data labeled as preliminary, or acknowledged limitations that would normally be addressed before submission create public review records that follow the paper indefinitely.

The model rewards papers that are ready for public evaluation, not papers that are nearly ready. Submitting before the data package is complete is riskier at eLife than at traditional journals.

Check whether your eLife public-review package is ready →

Papers submitted outside eLife's life-science scope

eLife covers biomedical and life sciences. We observe manuscripts from chemistry, physics, and materials science submitted to eLife because of its open-access model and fee structure. The editorial screen rejects these quickly. The scope boundary is more important at eLife than at multidisciplinary journals because eLife's reviewing editors are selected specifically for biological expertise.

Check whether your eLife scope framing is biological enough →

Significance framing that describes technical achievement rather than biological importance

eLife's eLife Assessment uses specific vocabulary: landmark, fundamental, important, valuable, useful. We find that manuscripts where the cover letter argues methodological innovation without connecting to biological significance receive "useful" or "valuable" assessments rather than "fundamental" or "landmark" assessments. The assessment vocabulary reflects the editorial filter. A new imaging method is not significant to eLife unless the biological insight it enables is stated clearly and specifically. Framing the contribution as a tool rather than a discovery misaligns with how eLife evaluates significance.

Check whether your eLife significance framing supports the assessment you want →

Authors reporting on SciRev (70 reports, read October 2026) describe a first review round at eLife that averages 1.6 months, with immediate rejections in about 11 days. An eLife biological significance and data completeness check can assess whether your manuscript's biological significance framing and data completeness meet eLife's bar before you submit.

In our pre-submission review work on eLife submissions, the decisive gate is the editorial decision to send a paper out for review at all: under eLife's reviewed-preprint model, papers that are reviewed are published with a public assessment, so the editors' initial screen on significance and fit is what actually filters. The work that gets reviewed makes a clear advance the editors judge important enough to assess in public. Focus on clearing that initial editorial screen with a sharp significance case; that is the real decision point at eLife.

This page was created by checking eLife's submit-your-research page, its reviewed-preprint model FAQ, peer-review model documentation, current fee language, SciRev timing benchmarks, and our pre-submission review work on life-science pre-submission reviews. Across the eLife-targeted manuscripts we review, the recurring issue was not only scientific strength but readiness for public assessment.

Use this guide when you understand eLife's scope but need the process decision: what happens after submission, what editors screen before public review, and what risks attach to the Reviewed Preprint model. If you want a manuscript-level check before entering a public-review workflow, use the eLife manuscript fit check.

Source limitations: eLife can update its process, fee, and Version of Record policies, so official guidance remains the final authority for submission mechanics. Use this guide for the editorial-readiness question competitors usually skip: whether the preprint, figures, limitation language, and author team are ready for public assessment.